Actively Recruiting

Phase 1
Age: 18Years - 55Years
All Genders
Healthy Volunteers
NCT07422207

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants

Led by Meiji Pharma USA Inc. · Updated on 2026-04-06

104

Participants Needed

1

Research Sites

66 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants

CONDITIONS

Official Title

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants

Who Can Participate

Age: 18Years - 55Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants aged 18 to 55 years at the time of consent
  • Participants must be in good general health based on medical history, physical exam, vital signs, ECG, and lab tests
  • Body weight greater than 45 kilograms at screening
  • Body mass index (BMI) between 18.0 and 30.0 kg/m² at screening
Not Eligible

You will not qualify if you...

  • History or current presence of serious infections like opportunistic infections, sepsis, or systemic fungal infections
  • History of pulmonary infiltrates or pneumonia within 6 months before screening
  • History or current autoimmune, cardiac, liver, kidney, gastrointestinal, respiratory, endocrine, neurological, central nervous system, mental, or blood disorders that could affect study participation
  • History or current malignancy of any organ, including skin basal cell carcinoma, whether treated or untreated
  • Other protocol-defined exclusion criteria may apply

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Scientia Clinical Reserch Ltd

Sydney, New South Wales, Australia, 2031

Actively Recruiting

Loading map...

Research Team

M

Meiji Pharma USA Inc. Study Lead

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here